Work

Targeting CD30 as therapy for Hodgkin’s disease. Phase II results with the monoclonal antibody SGN-30

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.2553

Authors: J. P. Leonard, A. Younes, J. D. Rosenblatt, A. Gopal, L. C. Pinter-Brown, N. L. Bartlett, L. J. Burns, A. Forero, J. Barton

Institutions: University of Minnesota, University of Washington, Cornell University, University of Alabama at Birmingham, Olive View-UCLA Medical Center, Sylvester Comprehensive Cancer Center, Weill Cornell Medicine

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2316835534

Cites:

Cited by: 6

Related to: 10